UBS AM’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5K Sell
21,643
-265,347
-92% -$190K ﹤0.01% 2614
2025
Q1
$422K Hold
286,990
﹤0.01% 2522
2024
Q4
$1.27M Buy
286,990
+17,265
+6% +$76.5K ﹤0.01% 2265
2024
Q3
$1.11M Sell
269,725
-38,965
-13% -$161K ﹤0.01% 2347
2024
Q2
$2.01M Buy
308,690
+158,175
+105% +$1.03M ﹤0.01% 1997
2024
Q1
$1.31M Sell
150,515
-6,487
-4% -$56.5K ﹤0.01% 1882
2023
Q4
$1.8M Buy
157,002
+23,086
+17% +$264K ﹤0.01% 1743
2023
Q3
$1.29M Sell
133,916
-22,455
-14% -$216K ﹤0.01% 1822
2023
Q2
$1.65M Hold
156,371
﹤0.01% 1763
2023
Q1
$1.65M Sell
156,371
-8,983
-5% -$94.5K ﹤0.01% 1763
2022
Q4
$2.05M Buy
165,354
+37,205
+29% +$461K ﹤0.01% 1510
2022
Q3
$1.33M Buy
128,149
+11,362
+10% +$118K ﹤0.01% 1803
2022
Q2
$1.35M Sell
116,787
-123,285
-51% -$1.42M ﹤0.01% 1813
2022
Q1
$3.02M Hold
240,072
﹤0.01% 1583
2021
Q4
$2.8M Sell
240,072
-989,038
-80% -$11.5M ﹤0.01% 1714
2021
Q3
$16.1M Sell
1,229,110
-676,165
-35% -$8.83M 0.01% 929
2021
Q2
$24.5M Buy
1,905,275
+49,189
+3% +$633K 0.01% 840
2021
Q1
$20.8M Sell
1,856,086
-588,177
-24% -$6.58M 0.01% 854
2020
Q4
$27.8M Sell
2,444,263
-1,009,979
-29% -$11.5M 0.01% 758
2020
Q3
$31.1M Sell
3,454,242
-2,986,625
-46% -$26.9M 0.02% 647
2020
Q2
$66.5M Sell
6,440,867
-1,415,024
-18% -$14.6M 0.04% 414
2020
Q1
$79.3M Sell
7,855,891
-888,342
-10% -$8.96M 0.06% 331
2019
Q4
$116M Sell
8,744,233
-1,913,331
-18% -$25.5M 0.07% 291
2019
Q3
$91.5M Buy
10,657,564
+458,799
+4% +$3.94M 0.06% 335
2019
Q2
$112M Buy
10,198,765
+1,692,670
+20% +$18.5M 0.08% 269
2019
Q1
$96.4M Sell
8,506,095
-296,860
-3% -$3.36M 0.07% 289
2018
Q4
$76.4M Buy
8,802,955
+1,413,768
+19% +$12.3M 0.07% 318
2018
Q3
$114M Sell
7,389,187
-325,402
-4% -$5.03M 0.08% 259
2018
Q2
$124M Buy
7,714,589
+817,135
+12% +$13.1M 0.09% 245
2018
Q1
$89.1M Sell
6,897,454
-694,421
-9% -$8.97M 0.07% 316
2017
Q4
$95.3M Sell
7,591,875
-58,333
-0.8% -$732K 0.08% 276
2017
Q3
$101M Buy
7,650,208
+3,351,486
+78% +$44.3M 0.09% 246
2017
Q2
$68M Buy
4,298,722
+2,695,463
+168% +$42.6M 0.07% 321
2017
Q1
$22.9M Buy
1,603,259
+1,542,466
+2,537% +$22M 0.02% 673
2016
Q4
$779K Sell
60,793
-29,694
-33% -$380K ﹤0.01% 1653
2016
Q3
$1.2M Buy
90,487
+1,671
+2% +$22.2K ﹤0.01% 1604
2016
Q2
$973K Buy
88,816
+2,201
+3% +$24.1K ﹤0.01% 1665
2016
Q1
$794K Sell
86,615
-29,134
-25% -$267K ﹤0.01% 1729
2015
Q4
$1.12M Buy
115,749
+3,831
+3% +$37.2K ﹤0.01% 1697
2015
Q3
$977K Buy
111,918
+37,058
+50% +$324K ﹤0.01% 1731
2015
Q2
$756K Buy
74,860
+14,686
+24% +$148K ﹤0.01% 1823
2015
Q1
$806K Buy
60,174
+8,239
+16% +$110K ﹤0.01% 1729
2014
Q4
$666K Sell
51,935
-239
-0.5% -$3.07K ﹤0.01% 1782
2014
Q3
$566K Buy
52,174
+1,074
+2% +$11.7K ﹤0.01% 1806
2014
Q2
$656K Buy
51,100
+2,747
+6% +$35.3K ﹤0.01% 1758
2014
Q1
$499K Buy
48,353
+4,537
+10% +$46.8K ﹤0.01% 1898
2013
Q4
$426K Buy
43,816
+13,850
+46% +$135K ﹤0.01% 1897
2013
Q3
$297K Hold
29,966
﹤0.01% 2086
2013
Q2
$250K Buy
+29,966
New +$250K ﹤0.01% 2124